Enforced telomere elongation increases the sensitivity of human tumour cells to ionizing radiation

DNA Repair

Volumn 25, Issue , 2015, Pages 54-59

  Fairlie, Jennifer ^a   Harrington, Lea ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

DNA damage; Gamma irradiation; Human tumour cells; Telomerase; Telomeres

Indexed keywords

CELL SURVIVAL; DNA DAMAGE; GAMMA RADIATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; RADIATION RESPONSE; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR CELL CULTURE;

CELL SURVIVAL; DNA DAMAGE; GAMMA RAYS; HUMANS; NEOPLASMS; TELOMERE; TELOMERE HOMEOSTASIS; TUMOR CELLS, CULTURED;

EID: 84914129031     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.11.005     Document Type: Article

References (48)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Harley C.B. Telomerase and cancer therapeutics. Nat. Rev. Cancer 2008, 8:167-179.
3. Artandi S.E., DePinho R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31:9-18.
4. Murnane J.P. Telomere dysfunction and chromosome instability. Mutat. Res. 2012, 730:28-36.
5. de Lange T., Shiue L., Myers M.R., Cox D.R., Naylor S.L., Killery A.M., Varmus H.E. Structure and variability of human chromosome ends. Mol. Cell. Biol. 1990, 10:518-527.
6. Lu L., Zhang C., Zhu G., Irwin M., Risch H., Menato G., Mitidieri M., Katsaros D., Yu H. Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res. 2011, 13:R56.
7. Harrington L. Haploinsufficiency and telomere length homeostasis. Mutat. Res. 2012, 730:37-42.
8. Compton S.A., Choi J.H., Cesare A.J., Ozgur S., Griffith J.D. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res. 2007, 67:1513-1519.
9. Oganesian L., Karlseder J. Mammalian 5' C-rich telomeric overhangs are a mark of recombination-dependent telomere maintenance. Mol. Cell 2011, 42:224-236.
10. Pickett H.A., Henson J.D., Au A.Y., Neumann A.A., Reddel R.R. Normal mammalian cells negatively regulate telomere length by telomere trimming. Hum. Mol. Genet. 2011, 20:4684-4692.
11. Wang R.C., Smogorzewska A., Lange de T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004, 119:355-368.
12. Watson J.M., Shippen D.E. Telomere rapid deletion regulates telomere length in Arabidopsis thaliana. Mol. Cell. Biol. 2007, 27:1706-1715.
13. Lustig A.J. Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion. Nat. Rev. Genet. 2003, 4:916-923.
14. Bhattacharyya M.K., Lustig A.J. Telomere dynamics in genome stability. Trends Biochem. Sci. 2006, 31:114-122.
15. Taboski M.A., Sealey D.C., Dorrens J., Tayade C., Betts D.H., Harrington L. Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis. Cell Rep. 2012, 1:91-98.
16. Boyd M., Ross S.C., Dorrens J., Fullerton N.E., Tan K.W., Zalutsky M.R., Mairs R.J. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. J. Nucl. Med. 2006, 47:1007-1015.
17. Taboski M.A.S., Sealey D.C.F., Dorrens J., Tayade C., Betts D.H., Harrington L. Long telomeres bypass the requirement for long telomeres in human tumorigenesis. Cell Rep. 2012, 1:91-98.
18. Kraemer K., Fuessel S., Kotzsch M., Ning S., Schmidt U., Wirth M.P., Meye A. Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatment. J. Urol. 2004, 172:2023-2028.
19. Chen Z., Koeneman K.S., Corey D.R. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Cancer Res. 2003, 63:5917-5925.
20. Cerone M.A., Londono-Vallejo J.A., Autexier C. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol. Cancer Ther. 2006, 5:1669-1675.
21. Tauchi T., Ohyashiki J.H., Ohyashiki K. Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect. Methods Mol. Biol. 2007, 405:181-189.
22. Misawa M., Tauchi T., Sashida G., Nakajima A., Abe K., Ohyashiki J.H., Ohyashiki K. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int. J. Oncol. 2002, 21:1087-1092.
23. Poynter K.R., Sachs P.C., Bright A.T., Breed M.S., Nguyen B.N., Elmore L.W., Holt S.E. Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells. Mol. Cancer Ther. 2009, 8:1319-1327.
24. Dong X., Liu A., Zer C., Feng J., Zhen Z., Yang M., Zhong L. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer 2009, 9:133.
25. Djojosubroto M.W., Chin A.C., Go N., Schaetzlein S., Manns M.P., Gryaznov S., Harley C.B., Rudolph K.L. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Hepatology 2005, 42:1127-1136.
26. Rubio M.A., Davalos A.R., Campisi J. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress. Exp. Cell Res. 2004, 298:17-27.
27. Ding Z., Wu C.J., Jaskelioff M., Ivanova E., Kost-Alimova M., Protopopov A., Chu G.C., Wang G., Lu X., Labrot E.S., Hu J., Wang W., Xiao Y., Zhang H., Zhang J., Zhang J., Gan B., Perry S.R., Jiang S., Li L., Horner J.W., Wang Y.A., Chin L., DePinho R.A. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 2012, 148:896-907.
28. Hu J., Hwang S.S., Liesa M., Gan B., Sahin E., Jaskelioff M., Ding Z., Ying H., Boutin A.T., Zhang H., Johnson S., Ivanova E., Kost-Alimova M., Protopopov A., Wang Y.A., Shirihai O.S., Chin L., DePinho R.A. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 2012, 148:651-663.
29. Patton E.E., Harrington L. Cancer: trouble upstream. Nature 2013, 495:320-321.
30. Heidenreich B., Rachakonda P.S., Hemminki K., Kumar R. TERT promoter mutations in cancer development. Curr. Opin. Genet. Dev. 2014, 24:30-37.
31. Lovejoy C.A., Li W., Reisenweber S., Thongthip S., Bruno J., de Lange T., De S., Petrini J.H., Sung P.A., Jasin M., Rosenbluh J., Zwang Y., Weir B.A., Hatton C., Ivanova E., Macconaill L., Hanna M., Hahn W.C., Lue N.F., Reddel R.R., Jiao Y., Kinzler K., Vogelstein B., Papadopoulos N., Meeker A.K. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 2012, 8:e1002772.
32. Neumann A.A., Watson C.M., Noble J.R., Pickett H.A., Tam P.P.L., Reddel R.R. Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev. 2013, 27:18-23.
33. Pickett H.A., Cesare A.J., Johnston R.L., Neumann A.A., Reddel R.R. Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J. 2009, 28:799-809.
34. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., Bucci G., Dobreva M., Matti V., Beausejour C.M., Herbig U., Longhese M.P., d'Adda di F., Fagagna Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 2012, 14:355-365.
35. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708.
36. Takai K.K., Hooper S., Blackwood S., Gandhi R., Lange de T. In vivo stoichiometry of shelterin components. J. Biol. Chem. 2010, 285:1457-1467.
37. Stewart J.A., Wang F., Chaiken M.F., Kasbek C., Chastain P.D., Wright W.E., Price C.M. Human CST promotes telomere duplex replication and general replication restart after fork stalling. EMBO J. 2012, 31:3537-3549.
38. Wang F., Stewart J.A., Kasbek C., Zhao Y., Wright W.E., Price C.M. Human CST has independent functions during telomere duplex replication and C-strand fill-in. Cell Rep. 2012, 2:1096-1103.
39. Chen L.Y., Lingner J. CST for the grand finale of telomere replication. Nucleus 2013, 4:277-282.
40. Chen L.Y., Redon S., Lingner J. The human CST complex is a terminator of telomerase activity. Nature 2012, 488:540-544.
41. Gao H., Cervantes R.B., Mandell E.K., Otero J.H., Lundblad V. RPA-like proteins mediate yeast telomere function. Nat. Struct. Mol. Biol. 2007, 14:208-214.
42. McEachern M.J., Blackburn E.H. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995, 376:403-409.
43. Yu G.L., Bradley J.D., Attardi L.D., Blackburn E.H. In vivo alteration of telomere sequences and senescence caused by mutated tetrahymena telomerase RNAs. Nature 1990, 344:126-132.
44. Bundock P., Hooykaas P. Severe developmental defects, hypersensitivity to DNA-damaging agents, and lengthened telomeres in Arabidopsis MRE11 mutants. Plant Cell 2002, 14:2451-2462.
45. Bundock P., van Attikum H., Hooykaas P. Increased telomere length and hypersensitivity to DNA damaging agents in an Arabidopsis KU70 mutant. Nucleic Acids Res. 2002, 30:3395-3400.
46. Riha K., Watson J.M., Parkey J., Shippen D.E. Telomere length deregulation and enhanced sensitivity to genotoxic stress in Arabidopsis mutants deficient in Ku70. EMBO J. 2002, 21:2819-2826.
47. Akimcheva S., Zellinger B., Riha K. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres. Cytogenet Genome Res. 2008, 122:388-395.
48. Ahmed S., Sheng H., Niu L., Henderson E. Tetrahymena mutants with short telomeres. Genetics 1998, 150:643-650.